Anita Sabichi
Assistant Professor, Medicine - Hematology & Oncology, Veterans Affairs Medical Center · Baylor College of Medicine
Credentials: · ·
History
- Present
- 1990–1992
Medical Oncology
- 1987–1990
Internal Medicine
Research
Benefits and harms of CT screening for lung cancer: a systematic review
Systematic review or meta-analysis · JAMA · 2012 · 986 citations
Clinical model of lifetime cost of treating bladder cancer and associated complications
Urology · 2006 · 243 citations
Review · Cancer Cell · 2004 · 238 citations
26 papers · 2 as a resident
- HG
14 papers
8 papers
6 papers
- JK
6 papers
- SL
5 papers
5 papers
4 papers
Grants
- 2024
Harnessing Allo-Immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC
Department of Veterans Affairs · I01
PI · Michael e Debakey Va Medical Center
- 1998–2003
Phase Ii Clinical Trial of Celecoxib or (Nsaid) in Bladd
National Cancer Institute · N01
Contact PI · $2.2M · University of Tx Md Anderson Can Ctr
Phase Ii Clinical Trial of Celecoxib or /Nsaid/ in Bladder Dysplasia --261985186
National Cancer Institute · N01
Contact PI · University of Texas/Md Anders
Phase Ii Clinical Trial of Celecoxib or (Nsaid) in Bladder Dysplasia --261085186
National Cancer Institute · N01
Contact PI · University of Texas/Md Anderso
Clinical trials
- 2000–2008
Celecoxib in Treating Patients With Bladder Cancer
Principal investigator · Completed · Phase 2, Phase 3
National Cancer Institute (NCI)
- 1998–2005
Fenretinide in Treating Patients Who Have Undergone Surgery for Bladder Cancer
Study chair · Completed · Phase 3
M.D. Anderson Cancer Center